PATENT CLAIM ANALYSIS

Application Number: 16031726
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "190100"]

Abstract:
This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including  Escherichia coli  and multi-drug resistant  E. coli . This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including  E. coli  and multi-drug resistant  E. coli.

Claim (Index 60):
The composition of  claim 52 , wherein the antigen is about 50 micrograms of truncated FimH.

Metadata:
- Claim Count in Document: 98.0
- Percentile: 95.0
- Lexical Diversity: 1.96
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15727615', '15947820', '15295287', '14663690', '15043452']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8288196540526069
- 35 USC 102 Novelty (BERT): 0.6093796761249834
- Combined Prediction Score: 0.8068756562598446
- Mean Citation Score: 613.79818
- Max Citation Score: 654.4032
- Similarity Product: 447.67916123256686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test